Monitoring Agency Report for the quarter ended March 2026
CARYSIL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
ICRA Limited has submitted the final Monitoring Agency Report for Q4 FY2026 for Carysil's QIP issue (Rs. 125 crore, opened July 2024). Net proceeds stand at Rs. 121.65 crore after a minor revision due to higher issue-related expenses. Of this, Rs. 87.86 crore (72%) has been utilized: Rs. 28.71 crore toward capital expenditure for new manufacturing facilities, Rs. 31.25 crore for working capital, and Rs. 27.90 crore for general corporate purposes. Rs. 33.79 crore remains unutilized, deployed in HDFC Bank fixed deposits earning Rs. 1.20 crore. The Board approved a timeline extension for capex utilization from March 2026 to March 2027. No material deviations were observed, and all statutory approvals and arrangements are in place.
The QIP funds are being deployed largely as planned with no red flags. The capex timeline extension suggests slower-than-anticipated machinery procurement, but this is disclosed and monitored. Shareholders can note that 72% of QIP proceeds have been deployed, with unutilized funds earning returns in FDs.